Jakarta, July 8 -- The Food and Drug Monitoring Agency (BPOM) said an mRNA-based dengue vaccine developed by the University of Indonesia and Tsinghua University could benefit not only Indonesia but also countries worldwide, and pledged support by ensuring its safety and efficacy.

BPOM Head Taruna Ikrar on Wednesday informed that approximately 390 million dengue infections occur worldwide each year.

Furthermore, data from the Ministry of Health shows that each year, around 161,000 people in Indonesia are infected with dengue, and about 700 die from the disease.

"This is an important discovery, and we can continue developing it further," Ikrar said at the launch of the mRNA Dengue Vaccine Prototype.

He explained that mRNA technology off...